PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $3.25 billion. The enterprise value is $3.00 billion.
Important Dates
The last earnings date was Thursday, April 24, 2025, before market open.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 55.33 million shares outstanding. The number of shares has increased by 8.95% in one year.
| Current Share Class | 55.33M |
| Shares Outstanding | 55.33M |
| Shares Change (YoY) | +8.95% |
| Shares Change (QoQ) | +2.00% |
| Owned by Insiders (%) | 2.63% |
| Owned by Institutions (%) | 92.56% |
| Float | 53.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.48 |
| Forward PS | 9.20 |
| PB Ratio | 8.31 |
| P/TBV Ratio | 8.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.95, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.95 |
| Quick Ratio | 7.60 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.00 |
Financial Efficiency
Return on equity (ROE) is -27.62% and return on invested capital (ROIC) is -14.73%.
| Return on Equity (ROE) | -27.62% |
| Return on Assets (ROA) | -13.36% |
| Return on Invested Capital (ROIC) | -14.73% |
| Return on Capital Employed (ROCE) | -20.63% |
| Revenue Per Employee | $329,525 |
| Profits Per Employee | -$119,303 |
| Employee Count | 756 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.27% in the last 52 weeks. The beta is 1.10, so PRCT's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -12.27% |
| 50-Day Moving Average | 55.63 |
| 200-Day Moving Average | 72.45 |
| Relative Strength Index (RSI) | 56.87 |
| Average Volume (20 Days) | 835,264 |
Short Selling Information
The latest short interest is 5.81 million, so 10.51% of the outstanding shares have been sold short.
| Short Interest | 5.81M |
| Short Previous Month | 6.07M |
| Short % of Shares Out | 10.51% |
| Short % of Float | 10.96% |
| Short Ratio (days to cover) | 4.66 |
Income Statement
In the last 12 months, PRCT had revenue of $249.12 million and -$90.19 million in losses. Loss per share was -$1.70.
| Revenue | 249.12M |
| Gross Profit | 156.23M |
| Operating Income | -96.40M |
| Pretax Income | -103.71M |
| Net Income | -90.19M |
| EBITDA | -90.88M |
| EBIT | -96.40M |
| Loss Per Share | -$1.70 |
Full Income StatementBalance Sheet
The company has $316.21 million in cash and $81.81 million in debt, giving a net cash position of $234.39 million or $4.24 per share.
| Cash & Cash Equivalents | 316.21M |
| Total Debt | 81.81M |
| Net Cash | 234.39M |
| Net Cash Per Share | $4.24 |
| Equity (Book Value) | 389.16M |
| Book Value Per Share | 7.04 |
| Working Capital | 413.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.91 million and capital expenditures -$4.30 million, giving a free cash flow of -$88.21 million.
| Operating Cash Flow | -83.91M |
| Capital Expenditures | -4.30M |
| Free Cash Flow | -88.21M |
| FCF Per Share | -$1.59 |
Full Cash Flow StatementMargins
Gross margin is 62.71%, with operating and profit margins of -38.70% and -36.20%.
| Gross Margin | 62.71% |
| Operating Margin | -38.70% |
| Pretax Margin | -36.20% |
| Profit Margin | -36.20% |
| EBITDA Margin | -36.48% |
| EBIT Margin | -38.70% |
| FCF Margin | n/a |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.95% |
| Shareholder Yield | -8.95% |
| Earnings Yield | -2.79% |
| FCF Yield | -2.73% |
Dividend DetailsAnalyst Forecast
The average price target for PRCT is $90.00, which is 53.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $90.00 |
| Price Target Difference | 53.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 25.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 16.59 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.59 |
| Piotroski F-Score | 4 |